Stein Gold, L., Bagel, J., Tyring, S. K., Hong, C.- ho, Pavlovsky, L., Pinter, A., Reich, A., Drogaris, L., Wu, T., Photowala, H., Stakias, V. ., Richter, S., & Papp, K. (2023). Efficacy and Safety of Risankizumab Compared with Apremilast in Patients with Moderate Plaque Psoriasis: Mean PASI and BSA Results From the Phase 4 IMMpulse Trial. SKIN The Journal of Cutaneous Medicine, 7(6), s257. https://doi.org/10.25251/skin.7.supp.257